Skip to the main content
The Crier

Red Cell Genotyping (PA2023)

NHS Blood and TransplantSouth Westgoodsabove thresholdFramework
Your saved contracts

What the buyer wrote

NHS Blood & Transplant (NHSBT) and Scottish National Blood Transfusion (SNBTS) Red Cell Immunohaematology (RCI) departments are awarding a supplier of red cell genotyping methods. The RCI laboratories in NHSBT and SNBTS provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. For some patients, the red cell phenotype cannot be determined due to prior transfusion, treatment with therapeutic monoclonal antibodies, or autoimmune conditions. For these patients, the selection of safe compatible blood for transfusion relies on red cell genotyping, a molecular method of determ…

Read all of it on Find a Tender →

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Sussex Biological Limited£1.6mends (31 Jan 2033)

Details

What the buyer calls it
Red Cell Genotyping (PA2023)
How they are buying
Advertised, then negotiatedThe buyer talked terms with bidders rather than taking fixed offers.
Type
goods
Framework
Yes: joining it lets you bid for call-offs without a new tender each time
Work starts
1 Feb 2026
Work ends
31 Jan 2033
Where
in the South West

Who the buyer named

The buyer published a contact address on this notice. Questions closed on 21 Aug 2025, 17:00 BST.

marta.drozdzowska@nhsbt.nhs.uk